LONG-TERM OUTCOMES OF CARDIAC RESYNCHRONIZATION THERAPY IN ASYMPTOMATIC HEART FAILURE PATIENTS

Patients with NYHA class II derive benefit from cardiac-resynchronization therapy (CRT), however, data on CRT effects in asymptomatic heart failure (NYHA class I) are limited. Patients with NYHA class I are not currently indicated for CRT. We assessed the effects of CRT-D vs. ICD on long-term